First total synthesis of sterenins A, C and D

Tetrahedron Letters

Volumn 49, Issue 10, 2008, Pages 1619-1622

  Shinozuka, Tsuyoshi ^a   Yamamoto, Yuko ^a   Hasegawa, Toru ^a   Saito, Keiji ^a   Naito, Satoru ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

11b HSDs; Claisen rearrangement; Isoindolinone; Metabolic diseases; Sterenin

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; HYDROXYL GROUP; LACTONE DERIVATIVE; NATURAL PRODUCT; PHENOL DERIVATIVE; STERENIN A; STERENIN C; STERENIN D; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL STRUCTURE; CLAISEN REARRANGEMENT; STEREOCHEMISTRY; SYNTHESIS;

EID: 38949106502     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2008.01.031     Document Type: Article

References (24)

1. Seckl J.R., and Walker B.R. Endocrinology 142 (2001) 1371-1376
2. Seckl J.R., and Walker B.R. Trends Endocrinol. Metab. 15 (2004) 418-424
3. Fotsch C., Askew B.C., and Chen J.C. Expert Opin. Ther. Pat. 15 (2005) 289-303
4. Overexpression of 11β-HSD1 in mouse adipose tissue leads to metabolic syndrome, see:. Masuzaki H., Paterson J., Shinyama H., Morton N.H., Mullins J.J., Seckl J.R., and FlierScience J.S. Science 294 (2001) 2166-2170
5. Masuzaki H., Yamamoto H., Kenyon C.J., Elmquist J.K., Morton N.M., Paterson J.M., Shinyama H., Sharp M.G.F., Fleming S., Mullins J.J., Seckl J.R., and Flier J.S. J. Clin. Invest. 112 (2003) 83-90
6. Aoyagi, A.; Ito-Kobayashi, M.; Tanaka, I.; Muramatsu, Y.; Umetani, M.; Takatsu, T. J. Antibiot., submitted for publication.
7. Aoyagi, A.; Tanaka, I.; Kobayashi, M. Jpn. Kokai Tokkyo Koho 291075, 2007.
8. 3,5-Bis(methoxy)-N,N-diethylbenzamide was metalated, see:. Watanabe M., Tsukazaki M., Hamada Y., Iwao M., and Furukawa S. Chem. Pharm. Bull. 37 (1989) 2948-2951
9. Brimble M.A., Caprio V., Johnston A.D., and Sidford M. Synthesis (2001) 855-862
10. Inoue A., Kitagawa K., Shinokubo H., and Oshima K. J. Org. Chem. 66 (2001) 4333-4339
11. Godfrey Jr. J.D., Mueller R.H., Sedergran T.C., Soundararajan N., and Colandrea V.J. Tetrahedron Lett. 35 (1994) 6405-6408
12. Cornella I., and Kelly T.R. J. Org. Chem. 69 (2004) 2191-2193
13. Nicolaou K.C., Xu H., and Wartmann M. Angew. Chem., Int. Ed. 44 (2005) 756-761
14. Norman M.H., Kelley J.L., and Hollingsworth E.B. J. Med. Chem. 36 (1993) 3417-3423
15. Norman M.H., Minick D.J., and Rigdon G.C. J. Med. Chem. 39 (1996) 149-157
16. Loubinoux B., Miazimbakana J., and Gerardin P. Tetrahedron Lett. 30 (1989) 1939-1942
17. Lee A.S., Hu Y.-J., and Chu S.-F. Tetrahedron 57 (2001) 2121-2126
18. Fomum Z.T., Ayafor J.F., Mbafor J.T., and Mbi C.M. J. Chem. Soc., Perkin Trans. 1 (1986) 33-37
19. Crombie L., and Crombie W.L. J. Chem. Soc., Perkin Trans. 1 (1982) 1455-1466
20. Parmar V.S., Sharmaa N.K., Husaina M., Wattersonc A.C., Kumarc J., Samuelsonc L.A., Chollic A.L., Prasada A.K., Kumara A., Malhotraa S., Kumara N., Jhaa A., Singha A., Singha I., Himanshua Vatsa A., Shakila N.A., Trikhaa S., Mukherjeea S., Sharmaa S.K., Singha S.K., Kumara A., Jhad H.N., Olsene C.E., Stovef C.P., Brackef M.E., and Mareel M.M. Bioorg. Med. Chem. 11 (2003) 913-929
21. Carboxylic acid 17 was prepared from commercially available ethyl 2,4-dihydroxy-6-methylbenzoate in two steps. See Supplementary data for detail.
22. Amine 21 was prepared from 2-aminoethanol. See Supplementary data for detail.
23. Castro A.M.M. Chem. Rev. 104 (2004) 2939-3002
24. Isopropyl 2-hydroxy-4-(methoxymethoxy)-6-methylbenzoate (28).